FindTrial
Sign In

Study on comparing the effectiveness of pericapsular nerve group block between ropivacaine and ropivacaine with dexmedetomidine in patients with hip fractures.

EVALUATION OF EFFECTIVENESS OF PERICAPSULAR NERVE GROUP(PENG) BLOCK WITH ROPIVACAINE VS ROPIVACAINE WITH DEXMEDETOMIDINE IN PATIENTS WITH HIP FRACTURES - A RANDOMIZED CONTROLLED STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060779
Enrollment
50
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Injection ropivacaine 0.25% 20 ml in PENG block: To find out the analgesic effectiveness and onset of pain relief during patient positioning and post operative analgesia of 0.25% ropiv

Sponsors

Dr k. Jeyanthi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASA grade 1,2 and 3 with hip fractures, posted for surgery under spinal anaesthesia who are unable to sit due to pain in the hip joint. Patients of either sex above 18 years of age.

Exclusion criteria

Exclusion criteria: Patients with hemorrhagic diasthesis, neurocognitive disorders,spinal deformities, psychiatric disorders. Patients with allergy to study drug. Patients with polytrauma, infection over injected site.

Design outcomes

Primary

MeasureTime frame
To compare the onset of pain relief & reduction in pain score(VAS)during the positioning of patients for central neuraxial blockade with 0.25% ropivacaine 20ml and 0.25% ropivacaine 20ml and dexmedetomidine 25 mcgTimepoint: duration of onset of pain relief will be noted at 5,10,15,20,30 minutes after the block—

Secondary

MeasureTime frame
To assess the duration of post operative pain relief in both groups & to assess the total analgesic requirements for 24 hoursTimepoint: 18 months—

Countries

India

Contacts

Public ContactDR.P.NAGALAKSHMI

SRI VENKATESHWARAA MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE

vedha83@gmail.com9894510137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026